F
AGN

FolioMetrix’s Allergan plc AGN Stock Holding History

FolioMetrix’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$1.2M Buy
5,487
+198
+4% +$59.1K 0.5% 39
2015
Q1 		$1.57M Buy
5,289
+1,149
+28% +$328K 0.79% 32
2014
Q4 		$875K Buy
+4,140
New +$1.03M 0.62% 41

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

FolioMetrix's AGN Position: Q2 2015 in Review

FolioMetrix increased its Allergan plc (AGN) stake by 3.7% in Q2 2015, buying an estimated $59.1K and bringing the position to 5,487 shares worth $1.2M. The position accounts for 0.5% of the portfolio, ranked #39.

FolioMetrix first reported a position in AGN in Q4 2014 and has held it in 3 quarters since. The position peaked at $1.57M in Q1 2015. 1,036 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • FolioMetrix held 5,487 shares of Allergan plc worth $1.2M as of Q2 2015.
  • FolioMetrix bought 198 Allergan plc shares in Q2 2015, an estimated $59.1K.
  • Allergan plc made up 0.5% of FolioMetrix's portfolio in Q2 2015, its #39 holding.
  • FolioMetrix first reported a position in Allergan plc in Q4 2014 and has held it in 3 quarters since.
  • FolioMetrix's Allergan plc position peaked at $1.57M in Q1 2015.
  • 1,036 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.